IMMUNOGENE ZUSAMMENSETZUNG

European patent · EP2903638 · Deleted

Register entry

Publication number
EP2903638
Application number
EP13792601
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 3, 2013
Published
Aug 12, 2015
Granted
Dec 18, 2019
Deleted
Apr 9, 2025
Reason
Revoked in opposition
IPC classes
A61K 39/09 (2006.01)
Priority
US 201261744880 P 03.10.2012
US 201361799123 P 15.03.2013
PCT application
PCT/EP2013/070656 03.10.2013
PCT publication
WO2014/053612 10.04.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 9, 2025

    Cancellation date

    Cancellation date
    31.10.2020 → 09.04.2025
    Cause for cancellation
    Non-payment of renewal fee → Opposition

    Published in Swissreg on 09.04.2025

  2. Feb 26, 2025

    Change

    Published in Swissreg on 26.02.2025

  3. Jun 28, 2023

    Change

    Published in Swissreg on 28.06.2023

  4. May 19, 2021

    Deleted, fee unpaid

    Published in Swissreg on 19.05.2021

  5. Dec 18, 2019

    Granted

    Published in Swissreg on 18.12.2019

Parties

Holder

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Inventor

MAIONE, Domenico

I-53100 Siena, IT

GRANDI, Guido

I-53100 Siena, IT

MARGARIT Y ROS, Immaculada

I-53100 Siena, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.